M
Mónica P. A. Ferreira
Researcher at University of Helsinki
Publications - 22
Citations - 888
Mónica P. A. Ferreira is an academic researcher from University of Helsinki. The author has contributed to research in topics: Drug delivery & Targeted drug delivery. The author has an hindex of 13, co-authored 22 publications receiving 570 citations.
Papers
More filters
Journal ArticleDOI
In vitro Evaluation of the Therapeutic Effects of Dual-Drug Loaded Spermine-Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
Giulia Torrieri,Mónica P. A. Ferreira,Mohammad-Ali Shahbazi,Mohammad-Ali Shahbazi,Mohammad-Ali Shahbazi,Virpi Talman,S. Tuuli Karhu,Lotta Pohjolainen,Cláudia Carvalho,João F. Pinto,Jouni Hirvonen,Heikki Ruskoaho,Vimalkumar Balasubramanian,Hélder A. Santos,Hélder A. Santos +14 more
Book ChapterDOI
Spray-drying for the formulation of oral drug delivery systems
TL;DR: This chapter discusses the formulation of drugs/drug delivery systems for oral administration using spray-drying, providing examples of micro/nano-particles and pure drug particles that have demonstrated the potential of this technology to overcome the limited bioavailability of drug formulations produced by other fabrication methods.
Journal ArticleDOI
Drug Delivery: Drug‐Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling (Small 33/2017)
Mónica P. A. Ferreira,Sanjeev Ranjan,Sini Kinnunen,Alexandra Correia,Virpi Talman,Ermei Mäkilä,Ermei Mäkilä,Brianda Barrios-Lopez,Marianna Kemell,Vimalkumar Balasubramanian,Jarno Salonen,Jouni Hirvonen,Heikki Ruskoaho,Anu J. Airaksinen,Hélder A. Santos +14 more
Book ChapterDOI
Chapter 3.5 - Current Trends and Developments for Nanotechnology in Cancer (Book Chapter)
Mónica P. A. Ferreira,Patrick V. Almeida,Mohammad-Ali Shahbazi,Alexandra Correia,Hélder A. Santos +4 more
TL;DR: In this paper, the authors focus on the current trends and developments of nanotechnology for cancer, highlighting some of the most advanced drug delivery nanosystems, targeting strategies, the nanotools used for cancer imaging and diagnostics as well as the recent nanotechnological approaches used in cancer immunotherapy.